Docoh
Loading...

MDXG Mimedx

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years
DFAN14A
MDXG Mimedx Group Inc
4 May 21
Additional proxy materials by non-management
5:00pm
DFAN14A
MDXG Mimedx Group Inc
4 May 21
Additional proxy materials by non-management
2:59pm
PREC14A
MDXG Mimedx Group Inc
20 Apr 21
Preliminary proxy with contested solicitation
5:47pm
PREC14A
MDXG Mimedx Group Inc
20 Apr 21
Preliminary proxy with contested solicitation
8:14am
DFAN14A
MDXG Mimedx Group Inc
16 Apr 21
Additional proxy materials by non-management
4:55pm
DFAN14A
MDXG Mimedx Group Inc
17 Jun 19
Additional proxy materials by non-management
11:00am
DFAN14A
MDXG Mimedx Group Inc
17 Jun 19
Additional proxy materials by non-management
10:55am
DFAN14A
MDXG Mimedx Group Inc
14 Jun 19
Additional proxy materials by non-management
5:11pm
DFAN14A
MDXG Mimedx Group Inc
12 Jun 19
Additional proxy materials by non-management
2:33pm
DFAN14A
MDXG Mimedx Group Inc
10 Jun 19
Additional proxy materials by non-management
5:27pm
DFAN14A
MDXG Mimedx Group Inc
10 Jun 19
Additional proxy materials by non-management
12:27pm
DFAN14A
MDXG Mimedx Group Inc
10 Jun 19
Additional proxy materials by non-management
12:26pm
DFAN14A
MDXG Mimedx Group Inc
10 Jun 19
Additional proxy materials by non-management
12:25pm
DFAN14A
MDXG Mimedx Group Inc
10 Jun 19
Additional proxy materials by non-management
12:23pm
DFRN14A
MDXG Mimedx Group Inc
7 Jun 19
Revised proxy by non-management
5:25pm
DFAN14A
MDXG Mimedx Group Inc
7 Jun 19
Additional proxy materials by non-management
5:25pm
DFAN14A
MDXG Mimedx Group Inc
6 Jun 19
Additional proxy materials by non-management
5:20pm
DFAN14A
MDXG Mimedx Group Inc
6 Jun 19
Additional proxy materials by non-management
5:15pm
DFAN14A
MDXG Mimedx Group Inc
4 Jun 19
Additional proxy materials by non-management
5:23pm
DFAN14A
MDXG Mimedx Group Inc
31 May 19
Additional proxy materials by non-management
5:26pm
DFRN14A
MDXG Mimedx Group Inc
31 May 19
Revised proxy by non-management
12:42pm
DFAN14A
MDXG Mimedx Group Inc
30 May 19
Additional proxy materials by non-management
4:52pm
PREC14A
MDXG Mimedx Group Inc
30 May 19
Preliminary proxy with contested solicitation
9:10am
DFAN14A
MDXG Mimedx Group Inc
29 May 19
Additional proxy materials by non-management
2:45pm
DFAN14A
MDXG Mimedx Group Inc
16 May 19
Additional proxy materials by non-management
3:14pm
PREC14A
MDXG Mimedx Group Inc
10 May 19
Preliminary proxy with contested solicitation
4:38pm
PREC14A
MDXG Mimedx Group Inc
9 May 19
Preliminary proxy with contested solicitation
5:25pm
DFAN14A
MDXG Mimedx Group Inc
8 May 19
Additional proxy materials by non-management
9:01am
DFAN14A
MDXG Mimedx Group Inc
7 May 19
Additional proxy materials by non-management
5:19pm
DFAN14A
MDXG Mimedx Group Inc
2 May 19
Additional proxy materials by non-management
3:51pm
DFAN14A
MDXG Mimedx Group Inc
29 Apr 19
Additional proxy materials by non-management
5:29pm
DFAN14A
MDXG Mimedx Group Inc
29 Apr 19
Additional proxy materials by non-management
4:07pm
DFAN14A
MDXG Mimedx Group Inc
16 Apr 19
Additional proxy materials by non-management
4:39pm
DFAN14A
MDXG Mimedx Group Inc
11 Apr 19
Additional proxy materials by non-management
5:17pm
Vote support at last AGM



On May 27, 2021, the Company held its 2021 Annual Meeting of shareholders (the “2021 Annual Meeting”). At the 2021 Annual Meeting, shares of Company common stock and Series B Preferred Stock representing 99,585,181 votes (i.e., approximately 75.7% of the votes entitled to be cast at the 2021 Annual Meeting) were represented in person or by proxy.




At the 2021 Annual Meeting, shareholders of the Company: (1) elected M. Kathleen Behrens, K. Todd Newton, and Timothy R. Wright as Class II directors; (2) elected Phyllis Gardner as a Class III director; (3) approved an advisory resolution regarding executive compensation; (4) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021; (5) approved an amendment to the Articles to declassify the board of directors of the Company (the “Board”); (6) approved an amendment to the Articles to reduce the ownership threshold to call a special shareholders’ meeting; and (7) approved an amendment to the Company’s Bylaws to adopt proxy access. Set forth below is information regarding the votes cast for each proposal:




Proposal 1: Election of Class II Directors.

ForAbstain/
Withhold
Broker Non-Votes
M. Kathleen Behrens66,034,4192,771,64030,779,122
K. Todd Newton67,793,5381,012,52130,779,122
Timothy R. Wright65,517,3283,288,73130,779,122








Proposal 2: Election of Class III Director.

ForAbstain/
Withhold
Broker Non-Votes
Phyllis Gardner57,920,74710,883,71730,779,122


Proposal 3: Advisory approval of executive compensation.

ForAgainstAbstainBroker Non-Votes
51,552,91614,557,5532,695,59030,779,122


Proposal 4: Ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;

ForAgainstAbstainBroker Non-Votes
98,912,496547,736124,949N/A





Proposal 5: Approved of an amendment to the Articles to declassify the Board.

ForAgainstAbstainBroker Non-Votes
67,640,7441,001,646163,66930,779,122

















Proposal 6: Approval of an amendment to the Articles to reduce the ownership threshold to call a special shareholders’ meeting.

ForAgainstAbstainBroker Non-Votes
67,315,1171,295,932195,01030,779,122





Proposal 7: Approval of an amendment to the Company’s Bylaws to adopt proxy access.




ForAgainstAbstainBroker Non-Votes
69,915,813686,839203,407300,779,122